Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Alaunos Therapeutics, Inc. | 44,167 | reported | 22 Jun 2022 | tx 6+320,010 |
| Viridian Therapeutics, Inc.\DE | 24,000 | reported | 21 May 2020 | tx 3+48,000 |
| Bicara Therapeutics Inc. | 19,475 | reported | 09 Jun 2026 | tx 2+43,221 |
| AGIOS PHARMACEUTICALS, INC. | 15,487 | reported | 18 Jun 2021 | tx 132+681,625−470,399 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jun 2026 | GRANT_AWARD | Bicara Therapeutics Inc. | 19,475 | 0.00 USD | deriv |
| 09 Jun 2025 | GRANT_AWARD | Bicara Therapeutics Inc. | 23,746 | 0.00 USD | deriv |
| 22 Jun 2022 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 40,000 | 0.00 USD | |
| 22 Jun 2022 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 18 Jun 2021 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 46,608 | 50.40 USD | |
| 18 Jun 2021 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 1,885 | 39.76 USD | |
| 18 Jun 2021 | SALE | AGIOS PHARMACEUTICALS, INC. | 48,493 | 60.11 USD | |
| 18 Jun 2021 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 46,608 | 0.00 USD | deriv |
| 18 Jun 2021 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 1,885 | 0.00 USD | deriv |
| 17 Jun 2021 | SALE | AGIOS PHARMACEUTICALS, INC. | 2,502 | 60.02 USD | |
| 17 Jun 2021 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2,502 | 39.76 USD | |
| 17 Jun 2021 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2,502 | 0.00 USD | deriv |
| 10 Jun 2021 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 20,853 | 39.76 USD | |
| 10 Jun 2021 | SALE | AGIOS PHARMACEUTICALS, INC. | 20,853 | 60.06 USD | |
| 09 Jun 2021 | SALE | AGIOS PHARMACEUTICALS, INC. | 7,149 | 60.16 USD | |
| 09 Jun 2021 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 7,149 | 39.76 USD | |
| 10 Jun 2021 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 20,853 | 0.00 USD | deriv |
| 09 Jun 2021 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 7,149 | 0.00 USD | deriv |
| 08 Jun 2021 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 6,675 | 39.76 USD | |
| 07 Jun 2021 | SALE | AGIOS PHARMACEUTICALS, INC. | 4,268 | 60.04 USD | |
| 07 Jun 2021 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 4,268 | 39.76 USD | |
| 08 Jun 2021 | SALE | AGIOS PHARMACEUTICALS, INC. | 6,675 | 60.07 USD | |
| 08 Jun 2021 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 6,675 | 0.00 USD | deriv |
| 07 Jun 2021 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 4,268 | 0.00 USD | deriv |
| 04 Mar 2021 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 4,167 | 0.00 USD |